Middle East and South Asia
Pfizer Inc. announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral...
Read more
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for...
Read more
Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine,...
Read more
Ankyra Therapeutics, a biotechnology company developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response, and...
Read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,...
Read more
Zydus Cadila has received restricted emergency use approval from the DCGI for the use of Pegylated Interferon alpha-2b (PegIFN) in...
Read more
The US FDA has accepted Airway Therapeutics’ Investigational New Drug (IND) application to develop AT-100 (rhSP-D) for treating Covid-19. A...
Read more
Pfizer Inc. and BioNTech SE requested amendments to the U.S. EUA of the Pfizer-BioNTech vaccine (BNT162b2) to expand the use...
Read more
INOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from...
Read more
Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced that...
Read moreLatest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.